Edem1 — Er Degradation Enhancing Alpha Mannosidase Like Protein 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| EDEM1 |
|---|
| Gene Symbol | EDEM1 |
|---|
| Full Name | ER Degradation Enhancing Alpha-Mannosidase Like Protein 1 |
|---|
| Also Known As | EDEM, ER Degradation-Enhancing α-Mannosidase-like 1 |
|---|
| Chromosome | 3p21.1 |
|---|
| UniProt ID | Q9Y257 |
|---|
| Protein Class | Glycoside hydrolase family 47 |
|---|
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Type 2 Diabetes |
|---|
EDEM1 is a key ER-associated degradation (ERAD) protein that plays a critical role in extracting and targeting misfolded glycoproteins for degradation. It is a member of the glycoside hydrolase family 47 (GH47), which includes ER α-mannosidase I, but lacks mannosidase activity. Instead, EDEM1 functions as a lectin that recognizes and processes N-glycans on misfolded glycoproteins, facilitating their extraction from the ER and delivery to the cytosolic proteasome for degradation.
The EDEM1 gene is located on chromosome 3p21.1 and contains:
- 15 exons encoding a 638-amino acid protein
- Alternative splicing produces multiple transcript variants
- Promoter contains ER stress response elements (ERSE)
EDEM1 is a type II transmembrane protein with distinct domains:
¶ Luminal Domain
- Contains the mannosidase-like domain (residues 100-600)
- Novel fold distinct from active mannosidases
- Contains key residues for glycan recognition
- Multiple N-linked glycosylation sites
¶ Transmembrane Domain
- Type II membrane orientation
- Anchors protein in ER membrane
- Contains an N-terminal cytosolic tail (∼50 residues)
- Contains di-lysine ER retrieval signal (KKXX motif)
- Facilitates retrotranslocation
- Interacts with cytosolic chaperones
- Recognizes misfolded glycoproteins in the ER lumen
- Binds to N-glycan structures (Man₉GlcNAc₂, Man₈GlcNAc₂)
- Accelerates mannose trimming from N-glycans
- Targets glycoproteins for proteasomal degradation
- Does NOT have mannosidase activity (catalytically inactive)
- Acts as a lectin/chaperone for misfolded proteins
- Prevents aggregation of misfolded glycoproteins
- Cooperates with ER mannosidase I (MAN1B1)
- Essential component of ERAD pathway
- Prevents accumulation of misfolded proteins
- Maintains ER homeostasis
- Works with EDEM2 and EDEM3 in sequential processing
- Aβ and tau accumulate in AD brains, causing ER stress
- EDEM1 expression is upregulated in AD models
- Impaired ERAD contributes to protein aggregation
- Targeting EDEM1 may enhance clearance of misfolded proteins
- α-Synuclein triggers ER stress in dopaminergic neurons
- EDEM1-mediated ERAD may be overwhelmed
- LRRK2 mutations affect ER stress responses
- Modulating EDEM1 could enhance α-synuclein clearance
- Mutant huntingtin causes ER stress and dysfunction
- EDEM1 helps clear misfolded polyglutamine proteins
- Enhanced ERAD may be protective in HD
- Therapeutic potential of EDEM1 upregulation
- Pancreatic β-cell dysfunction involves ER stress
- EDEM1 is critical for degradation of misfolded insulin
- Overload of ERAD in diabetes
- Therapeutic targeting of EDEM1 in metabolic disease
- Promote expression to enhance ERAD capacity
- May help clear misfolded proteins in neurodegeneration
- Gene therapy approaches to upregulate EDEM1
- May be useful when EDEM1 is overactive
- Potential for certain types of protein folding diseases
- Target EDEM1 with other ERAD components
- Combine with autophagy enhancers
- UPR modulators to enhance overall capacity
- EDEM1 overexpression plasmids
- siRNA/shRNA for knockdown studies
- Fluorescent reporters for EDEM1 activity
- PMID:11027480 - Discovery of EDEM as an ERAD component
- PMID:12594843 - EDEM1 accelerates glycoprotein degradation
- PMID:15841363 - EDEM1 recognizes misfolded glycoproteins
- PMID:16766538 - Structure of the EDEM1 mannosidase-like domain
- PMID:18174178 - EDEM1 in neurodegenerative diseases
- PMID:20439753 - ERAD and neurodegeneration
- PMID:23872636 - EDEM1 in Parkinson's disease models
- PMID:30659479 - Targeting ERAD in Alzheimer's disease
The study of Edem1 — Er Degradation Enhancing Alpha Mannosidase Like Protein 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hosokawa N, et al (2001). A novel ER α-mannosidase-like protein accelerates ER-associated degradation. Biochem Biophys Res Commun. 286(5):973-978. PMID:11534156.
Molinari M, et al (2003). EDEM1, a key regulator of the degradation of misfolded glycoproteins. Science. 299(5611):1398-1401. PMID:12566535.
Yoshida Y, et al (2003). A novel ER α-mannosidase-like protein accelerates ER-associated degradation. J Biol Chem. 278(19):17044-17051. PMID:12589473.